论文部分内容阅读
目的探讨经尿道等离子双极汽化电切术(TUPKVP)治疗高危前列腺增生症(BPH)的安全性及疗效。方法采用TUPKVP治疗高危BPH患者78例。结果手术切除前列腺重量(16～122)g,平均(43.2±28.3)g,出血(30～126)ml,平均(55±23)ml,无出现TURS、尿失禁、闭孔神经反射,术后3个月最大尿流率(Qmax)由术前(7.2±4.3)升至术后(17.6±3.4)ml/s,IPSS评分由术前(22.4±5.7)降至术后(7.1±4.2),生存质量评分(QOL)由术前(4.2±0.9)降至术后(1.0±0.7),残余尿量(RUV)由术前(62.1±33.2)ml降至术后(6.8±5.6)ml。结论TUPKVP是BPH的安全有效的治疗方法,TUPKVP的汽化止血效果更好,更能减少TURS的发生,尤其适合高危的BPH患者。
Objective To investigate the safety and efficacy of transurethral plasma-assisted bipolar vaporization (TUPKVP) in the treatment of high-risk benign prostatic hyperplasia (BPH). Methods TUPKVP treatment of high-risk BPH patients 78 cases. Results Total prostatectomy (16-122) g, mean (43.2 ± 28.3) g, bleeding (30-126) ml, mean (55 ± 23) ml, no TURS, urinary incontinence, obturator nerve reflex, The maximal flow rate (Qmax) increased from 7.2 ± 4.3 to 17.6 ± 3.4 ml / s at 3 months, and the IPSS decreased from 22.4 ± 5.7 to 7.1 ± 4.2 after operation (QOL) from preoperative (4.2 ± 0.9) to postoperative (1.0 ± 0.7) and residual urine volume (RUV) from preoperative (62.1 ± 33.2) ml to postoperative (6.8 ± 5.6) ml . Conclusion TUPKVP is a safe and effective treatment for BPH. TUPKVP has a better effect of vaporization and hemostasis, which can reduce the incidence of TURS, especially for high-risk BPH patients.